Armando López‐Guillermo

Research interests

Publications

• The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

  Blood · 2022 · https://doi.org/10.1182/blood.2022015851

• Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1801445

• Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

  Blood · 2016 · 10.1182/blood-2015-07-659144

• Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2015 · 10.1093/annonc/mdv304

• Non-coding recurrent mutations in chronic lymphocytic leukaemia

  Nature · 2015 · https://doi.org/10.1038/nature14666

• Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

  Proceedings of the National Academy of Sciences · 2013 · 10.1073/pnas.1314608110

• Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia

  Nature Genetics · 2012 · https://doi.org/10.1038/ng.2443

• Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

  Nature Genetics · 2011 · 10.1038/ng.1032

• Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

  Blood · 2011 · 10.1182/blood-2010-12-322362

• Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

  Nature · 2011 · https://doi.org/10.1038/nature10113

• CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

  The Lancet Oncology · 2011 · 10.1016/s1470-2045(11)70235-2

• Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

  The Lancet · 2010 · 10.1016/s0140-6736(10)62175-7

• Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

  Cancer Research · 2010 · 10.1158/0008-5472.can-09-3419

• Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

  Journal of Clinical Oncology · 2009 · 10.1200/jco.2008.21.3991

• Stromal Gene Signatures in Large-B-Cell Lymphomas

  New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmoa0802885

• CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

  The Lancet Oncology · 2006 · https://doi.org/10.1016/s1470-2045(06)70664-7

• High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma

  Blood · 2006 · 10.1182/blood-2006-04-018218

• Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’ 1

  British Journal of Haematology · 2004 · 10.1111/j.1365-2141.2004.05177.x

• Diffuse Large B-cell Lymphomas With Plasmablastic Differentiation Represent a Heterogeneous Group of Disease Entities

  The American Journal of Surgical Pathology · 2004 · 10.1097/01.pas.0000126781.87158.e3

• Follicular lymphoma international prognostic index.

  PubMed · 2004 · 10.1182/blood-2003-12-4434

• Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

  The Journal of Experimental Medicine · 2003 · 10.1084/jem.20031074

• ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia

  New England Journal of Medicine · 2003 · 10.1056/nejmoa023143

• Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

  Blood · 2003 · 10.1182/blood-2002-04-1279

• The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

  New England Journal of Medicine · 2002 · https://doi.org/10.1056/nejmoa012914

• PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma

  Blood · 1994 · 10.1182/blood.v84.8.2726.2726

Current projects

No projects listed.